Track the Molecular Partners AG share price and the full insider trade history of the company, a listed equity based in Switzerland. Shares are listed on CH CH, under the authority of SIX SER. Operating in the Health Care sector, Molecular Partners AG has logged 6 public disclosures. Market capitalisation: €118.2m. The latest transaction was reported on 2 April 2026 (Sale). The full history is openly available.
6
Insider Decl.
n/a
Thresholds
€32,994
1 ops.
Buy Volume
€497,857
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Molecular Partners AG Buy (bullish), based on 2 analysts. Average price target: CHF 9.00.
26Σ signal
Buys €32,994€497,857 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 April 2026
Declarations6 total
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior management·Executives·
10,000 shares@ CHF 3.17610.026% mcap100.0% of flowSIX:T1NB100071
6 of 6 declarations
About Molecular Partners AG
Molecular Partners AG is a Swiss biopharmaceutical company focused on developing protein-based therapies. It is listed on the Swiss stock exchange XSWX.